Chronic Lymphocytic Leukemia Clinical Trials

A listing of Chronic Lymphocytic Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Kentucky

UPDATED

Louisville Kentucky 40207

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Maryland

UPDATED

Baltimore Maryland 21229

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Michigan

UPDATED

Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Mississippi

UPDATED

Jackson Mississippi 39216

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

New Jersey

UPDATED

Hackensack New Jersey 07601

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

New York

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Ohio

UPDATED

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating ARQ 531

Oregon

UPDATED

Portland Oregon 97239

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19111

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

Tennessee

UPDATED

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study evaluating ARQ 531

Texas

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

UPDATED

Houston Texas 77030-4009

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study to evaluate Hematopoietic/Lymphoid Cancer

UPDATED

San Antonio Texas 78229

Patients are needed to participate in a clinical research study evaluating ASN002 Dose Escalation and ASN002 MTD

UPDATED

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Utah

UPDATED

Salt Lake City Utah 84112

Patients are needed to participate in a clinical research study evaluating ARQ 531

Virginia

UPDATED

Fairfax Virginia 22031

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Washington

UPDATED

Spokane Valley Washington 99216

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

West Virginia

UPDATED

Morgantown West Virginia 26506

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Wisconsin

UPDATED

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study of ADCT-301 to evaluate Hodgkin Lymphoma or Non-Hodgkin Lymphoma

Austria

UPDATED

Graz 8036

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Salzburg 5020

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Vienna 1140

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Belgium

UPDATED

Brussels 1200

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Leuven 3000

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Canada

UPDATED

Hailfax B3H 2Y9

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Hamilton L8V 1C3

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Quebec GIJ 1Z4

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Toronto M4N 3M5

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Vancouver V5Z 4E6

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Denmark

UPDATED

Aarhus, Jylland 8000

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Herlev 2730

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Finland

UPDATED

Turku 20521

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

France

UPDATED

Bordeaux, Cedex 33076

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

BREST Cedex 29609

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Limoges 87042

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Poitiers Cedex 86021

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Strasbourg 67000

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

Germany

UPDATED

Amberg 92224

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Aschaffenburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Berlin 10707

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Bremen

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Dortmund

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

View More ▼

UPDATED

Essen Nordrhein-westfalen

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Frankfurt 60389

A clinical research study of Venetoclax for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Freiburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Hamburg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Heidelberg

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Kaiserslautern

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Kiel

Patients are needed to participate in a clinical research study evaluating GS-4059, Entospletinib and Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia